Hypothalamic‐pituitary‐adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one‐week randomized Phase 1b trial

BACKGROUND: Arginine vasopressin 1B receptor (V(1B)) antagonists may have utility for the treatment of major depressive disorder (MDD). METHODS: The V(1B) antagonist ABT‐436 (N = 31) or matching placebo (N = 20) was administered to MDD subjects for 7 days. The main study objectives were to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, David A., Locke, Charles, Greco, Nicholas, Liu, Wei, Tracy, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346517/
https://www.ncbi.nlm.nih.gov/pubmed/28293470
http://dx.doi.org/10.1002/brb3.628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346517/
https://www.ncbi.nlm.nih.gov/pubmed/28293470
http://dx.doi.org/10.1002/brb3.628

Ejemplares similares